Meeting
2019 ASCO Annual Meeting
Characterization of 648 non-small cell lung cancer (NSCLC) cases with 28 unique HER2 exon 20 insertions.
Authors
Sai-Hong Ignatius Ou
Chao Family Comprehensive Cancer Center, University of California, Orange, CA
Sai-Hong Ignatius Ou , Russell Madison , Jacqulyne Ponville Robichaux , Jeffrey S. Ross , Vincent A. Miller , Siraj Mahamed Ali , Alexa Betzig Schrock , John Heymach
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9063)
DOI
10.1200/JCO.2019.37.15_suppl.9063
Abstract #
9063
Poster Bd #
386
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Targeted therapy for non-small cell lung cancer (NSCLC) with HER2, BRAF, or hedgehog alterations: Interim data from MyPathway.
First Author: John D. Hainsworth
Poster
2022 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and responses in NSCLC HER2 exon 20 insertion treated with poziotinib.
First Author: Arunthi Thiagalingam
Poster
2022 ASCO Annual Meeting
Molecular characteristics of ERBB2-activating mutations in Chinese patients with NSCLC.
First Author: Fan Xu
Poster
2020 ASCO Virtual Scientific Program
MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA.
First Author: Emily S. Lebow